Organogenesis Holdings Inc. (ORGO) Earnings Call Analysis
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Organogenesis (ORGO) Q1 2026: 58% Revenue Drop Forces $14M Cost Reset, Delays Recovery to Q4
May 08, 2026
-
OrganiGenesis (ORGO) Q4 2025: Advanced Wound Care Soars 83%, But CMS Policy Disruption Signals 2026 Revenue Drop
February 27, 2026
-
Organogenesis (ORGO) Q3 2025: Advanced Wound Care Surges 31% as CMS Policy Shift Unlocks Margin Tailwind
November 07, 2025
-
OrganoGenesis (ORGO) Q2 2025: Surgical and Sports Medicine Up 16% as CMS Payment Reform Reshapes Outlook
August 08, 2025
-
Organogenesis (ORGO) Q1 2025: Portfolio Optionality Counters 21% Revenue Drop Amid LCD Delay
July 05, 2025